Cardiff Oncology (CRDF) Leases (2019 - 2025)
Historic Leases for Cardiff Oncology (CRDF) over the last 7 years, with Q3 2025 value amounting to $764000.0.
- Cardiff Oncology's Leases fell 4141.1% to $764000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $764000.0, marking a year-over-year decrease of 4141.1%. This contributed to the annual value of $1.2 million for FY2024, which is 3155.74% down from last year.
- Latest data reveals that Cardiff Oncology reported Leases of $764000.0 as of Q3 2025, which was down 4141.1% from $899000.0 recorded in Q2 2025.
- Over the past 5 years, Cardiff Oncology's Leases peaked at $3.0 million during Q3 2021, and registered a low of $178000.0 during Q2 2021.
- Its 5-year average for Leases is $1.7 million, with a median of $1.7 million in 2023.
- Its Leases has fluctuated over the past 5 years, first crashed by 6453.43% in 2021, then surged by 131797.75% in 2022.
- Quarter analysis of 5 years shows Cardiff Oncology's Leases stood at $2.8 million in 2021, then dropped by 19.49% to $2.3 million in 2022, then dropped by 24.12% to $1.7 million in 2023, then plummeted by 31.56% to $1.2 million in 2024, then plummeted by 34.64% to $764000.0 in 2025.
- Its last three reported values are $764000.0 in Q3 2025, $899000.0 for Q2 2025, and $1.0 million during Q1 2025.